Gene Therapy Market: A Strong Pipeline with $12 Billion Opportunity by 2030

Gene therapies have shown significant potential in the preclinical studies, as well as clinical trials. For instance, a study that was published in The New England Journal of Medicine showed that seven of the babies suffering from SCID, when treated with gene therapy, developed immune systems that can protect them against common childhood ailments. In fact, we now have gene therapies being developed for some of the more common indications, such as Alzheimer’s.

Leave a Reply

Your email address will not be published. Required fields are marked *